# Gregory H. Reaman

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/gregory-h-reaman/

## Facts

| Field | Value |
| --- | --- |
| Citations | 28,150 |
| Field | Acute Lymphoblastic Leukemia research |
| h-index | 88 |
| i10-index | 267 |
| Last Known Institution | National Cancer Institute |
| OpenAlex ID | https://openalex.org/A5019914745 |
| ORCID iD | https://orcid.org/0000-0002-6698-4503 |
| Works | 472 |

## Researcher papers

- [Outcome for children with medulloblastoma treated with radiation and cisplatin, CCNU, and vincristine chemotherapy](https://scholariq.org/papers/outcome-for-children-with-medulloblastoma-treated-with-radiation-and-cisplatin/)
- [Maternal Diet and Infant Leukemia: The DNA Topoisomerase II Inhibitor Hypothesis: A Report from the Children's Oncology Group](https://scholariq.org/papers/maternal-diet-and-infant-leukemia-the-dna-topoisomerase-ii-inhibitor-hypothesis/)

## Researcher topics

- [Acute Lymphoblastic Leukemia research](https://scholariq.org/topics/acute-lymphoblastic-leukemia-research/)
- [Childhood Cancer Survivors' Quality of Life](https://scholariq.org/topics/childhood-cancer-survivors-quality-of-life/)
- [Neuroblastoma Research and Treatments](https://scholariq.org/topics/neuroblastoma-research-and-treatments/)
- [Acute Myeloid Leukemia Research](https://scholariq.org/topics/acute-myeloid-leukemia-research/)
- [Pharmaceutical studies and practices](https://scholariq.org/topics/pharmaceutical-studies-and-practices/)

## Researcher university

- [National Cancer Institute](https://scholariq.org/institutions/national-cancer-institute-3/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.
